PH31209A - Adhesive composition and method. - Google Patents
Adhesive composition and method.Info
- Publication number
- PH31209A PH31209A PH46630A PH46630A PH31209A PH 31209 A PH31209 A PH 31209A PH 46630 A PH46630 A PH 46630A PH 46630 A PH46630 A PH 46630A PH 31209 A PH31209 A PH 31209A
- Authority
- PH
- Philippines
- Prior art keywords
- adhesive composition
- adhesive
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929216649A GB9216649D0 (en) | 1992-08-05 | 1992-08-05 | Amide derivatives |
GB939307958A GB9307958D0 (en) | 1993-04-17 | 1993-04-17 | Amide derivateves |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31209A true PH31209A (en) | 1998-05-05 |
Family
ID=26301376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH46630A PH31209A (en) | 1992-08-05 | 1993-08-04 | Adhesive composition and method. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5585374A (sv) |
EP (1) | EP0664801A1 (sv) |
JP (1) | JPH08501287A (sv) |
KR (1) | KR950702978A (sv) |
AU (1) | AU675964B2 (sv) |
CA (1) | CA2141810A1 (sv) |
FI (1) | FI950486A0 (sv) |
HU (2) | HUT71899A (sv) |
PH (1) | PH31209A (sv) |
TW (1) | TW288017B (sv) |
WO (1) | WO1994003444A1 (sv) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9314758D0 (en) * | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
GB9410512D0 (en) * | 1994-05-25 | 1994-07-13 | Smithkline Beecham Plc | Novel treatment |
US5525600A (en) * | 1994-11-28 | 1996-06-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
US6436964B1 (en) * | 1998-06-30 | 2002-08-20 | Eli Lilly And Company | Piperidine derivatives having effects on serotonin related systems |
US6465453B1 (en) | 1998-06-30 | 2002-10-15 | Eli Lilly And Company | Azepine derivatives having effects on serotonin related systems |
AU4850199A (en) | 1998-06-30 | 2000-01-17 | Eli Lilly And Company | Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
SK286701B6 (sk) * | 2000-07-21 | 2009-03-05 | H. Lundbeck A/S | Indolové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
US6861427B2 (en) * | 2001-04-26 | 2005-03-01 | Wyeth | Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists |
US20040058962A1 (en) * | 2002-06-14 | 2004-03-25 | Amedeo Leonardi | Phenylalkylamines and pyridylalkylamines |
ITMI20021329A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilammine sostituite |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3221018A (en) * | 1964-04-07 | 1965-11-30 | Aldrich Chem Co Inc | N-cyclopropyl amides of 4-phenyl-1,2,5,6-tetrahydropyridino alkanoic acids and intermediates thereof |
US3221019A (en) * | 1964-04-07 | 1965-11-30 | Aldrich Chem Co Inc | N-alkinyl and n-alkinyloxy-amides of 4-phenyl - 1,2,5,6 - tetrahydropyridino alkanoic acids and intermediates thereof |
NL173848C (nl) * | 1970-06-01 | 1984-03-16 | Janssen Pharmaceutica Nv | Werkwijze ter bereiding van 2.2-diaryl 4-piperidino butyramiden; werkwijze ter bereiding van therapeutisch werkzame preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen. |
FR2533924A1 (fr) * | 1982-10-05 | 1984-04-06 | Roussel Uclaf | Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant |
DK172696B1 (da) * | 1987-08-13 | 1999-05-31 | Glaxo Group Ltd | Indolderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende forbindelserne |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
US5240942A (en) * | 1990-07-10 | 1993-08-31 | Adir Et Compagnie | Piperidine, tetrahydropyridine and pyrrolidine compounds |
US5242933A (en) * | 1990-07-10 | 1993-09-07 | Adir Et Compagnie | Piperidine, tetrahydropyridine and pyrrolidine compounds |
FR2664592B1 (fr) * | 1990-07-10 | 1994-09-02 | Adir | Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
AU644488B2 (en) * | 1990-10-19 | 1993-12-09 | John Wyeth & Brother Limited | Piperazine derivatives |
GB9022790D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5250542A (en) * | 1991-03-29 | 1993-10-05 | Eli Lilly And Company | Peripherally selective piperidine carboxylate opioid antagonists |
US5525600A (en) * | 1994-11-28 | 1996-06-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
-
1993
- 1993-07-22 CA CA002141810A patent/CA2141810A1/en not_active Abandoned
- 1993-07-22 US US08/379,579 patent/US5585374A/en not_active Expired - Lifetime
- 1993-07-22 JP JP6505080A patent/JPH08501287A/ja active Pending
- 1993-07-22 WO PCT/GB1993/001542 patent/WO1994003444A1/en not_active Application Discontinuation
- 1993-07-22 EP EP93917886A patent/EP0664801A1/en not_active Ceased
- 1993-07-22 HU HU9500330A patent/HUT71899A/hu unknown
- 1993-07-22 KR KR1019950700456A patent/KR950702978A/ko not_active Application Discontinuation
- 1993-07-22 AU AU47145/93A patent/AU675964B2/en not_active Ceased
- 1993-08-02 TW TW082106155A patent/TW288017B/zh active
- 1993-08-04 PH PH46630A patent/PH31209A/en unknown
-
1995
- 1995-02-03 FI FI950486A patent/FI950486A0/sv not_active Application Discontinuation
- 1995-06-29 HU HU95P/P00599P patent/HU211591A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
TW288017B (sv) | 1996-10-11 |
HUT71899A (en) | 1996-02-28 |
US5585374A (en) | 1996-12-17 |
HU9500330D0 (en) | 1995-03-28 |
WO1994003444A1 (en) | 1994-02-17 |
CA2141810A1 (en) | 1994-02-17 |
AU4714593A (en) | 1994-03-03 |
HU211591A9 (en) | 1995-12-28 |
JPH08501287A (ja) | 1996-02-13 |
AU675964B2 (en) | 1997-02-27 |
KR950702978A (ko) | 1995-08-23 |
FI950486A (sv) | 1995-02-03 |
EP0664801A1 (en) | 1995-08-02 |
FI950486A0 (sv) | 1995-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9210057B (en) | Adhesive composition and method | |
GR3026535T3 (en) | Water-dispersible adhesive composition and process | |
AU7270091A (en) | Method and composition for coiontophoresis | |
AU1669395A (en) | Antiviral or antifungal composition and method | |
ZA932058B (en) | Adhesive and sealing composition | |
AU6400294A (en) | Tripterinin compound and method | |
AU6955594A (en) | Aminoureaformaldehyde fertilizer method and composition | |
EP0734398A4 (en) | COMPOUNDS AND METHODS | |
PH31209A (en) | Adhesive composition and method. | |
GB2281830B (en) | I/q-modulator and i/q-demodulator | |
AU6368394A (en) | Polymer-polypeptide composition and method | |
AU7014991A (en) | Carrier composition and method | |
ZA93582B (en) | Substituted hexahyhdroazephinones and tetrahydrobenzazepinones | |
GB9224295D0 (en) | Method and composition | |
HU9402155D0 (en) | Azin-derivatives and insekticidal composition containing them | |
GB9420539D0 (en) | Process and composition | |
GB9508546D0 (en) | Method and composition | |
GB9414888D0 (en) | Method and composition | |
GB9419087D0 (en) | Method and composition | |
GB9000802D0 (en) | Bonding method and assembly for use therein | |
GB9026896D0 (en) | Method and composition | |
ZA93644B (en) | Adhesive. | |
GB9308051D0 (en) | Method and composition | |
GB9211591D0 (en) | Method and composition | |
GB9310729D0 (en) | Method and composition |